77 related articles for article (PubMed ID: 15023824)
1. Juvenile Parkinson disease and the C212Y mutation of parkin.
Ruiz-Linares A
Arch Neurol; 2004 Mar; 61(3):444; author reply 444. PubMed ID: 15023824
[No Abstract] [Full Text] [Related]
2. A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia.
Pineda-Trujillo N; Carvajal-Carmona LG; Buriticá O; Moreno S; Uribe C; Pineda D; Toro M; García F; Arias W; Bedoya G; Lopera F; Ruiz-Linares A
Neurosci Lett; 2001 Feb; 298(2):87-90. PubMed ID: 11163284
[TBL] [Abstract][Full Text] [Related]
3. Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.
Morales B; Martínez A; Gonzalo I; Vidal L; Ros R; Gomez-Tortosa E; Rabano A; Ampuero I; Sánchez M; Hoenicka J; García De Yébenes J
Mov Disord; 2002 Nov; 17(6):1374-80. PubMed ID: 12465088
[TBL] [Abstract][Full Text] [Related]
4. The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants.
Mitsuyama S; Ohtsubo M; Minoshima S; Shimizu N
Hum Mutat; 2015 Aug; 36(8):E2430-40. PubMed ID: 25907632
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of Juvenile parkinsonism with bilateral subthalamic deep brain stimulation in a 14-year-old patient with parkin gene mutation.
Genç G; Apaydın H; Gündüz A; Poyraz Ç; Oğuz S; Yağcı S; Canaz H; Aydın S; Gündoğdu-Eken A; Başak AN; Ertan S
Parkinsonism Relat Disord; 2016 Mar; 24():137-8. PubMed ID: 26830385
[No Abstract] [Full Text] [Related]
6. How to predict the risk of Parkinson disease in relatives of parkin mutation carriers: a complex puzzle of age, penetrance, and number of mutated alleles.
Klein C; Ziegler A
Arch Neurol; 2008 Apr; 65(4):443-4. PubMed ID: 18413465
[No Abstract] [Full Text] [Related]
7. Pseudo-orthostatic and resting leg tremor in a large Spanish family with homozygous truncating parkin mutation.
Infante J; Berciano J; Sánchez-Juan P; García A; Di Fonzo A; Breedveld G; Oostra B; Bonifati V
Mov Disord; 2009 Jan; 24(1):144-7. PubMed ID: 18951541
[No Abstract] [Full Text] [Related]
8. Diagnostic considerations in juvenile parkinsonism.
Paviour DC; Surtees RA; Lees AJ
Mov Disord; 2004 Feb; 19(2):123-35. PubMed ID: 14978667
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the Parkin gene in a Persian family: clinical progression over a 40-year period.
Clarimon J; Johnson J; Djaldetti R; Hernandez D; Hattori N; Sroka H; Barhom Y; Singleton A
Mov Disord; 2005 Jul; 20(7):887-90. PubMed ID: 15852366
[TBL] [Abstract][Full Text] [Related]
10. Gene symbol: PARK2. Disease: Parkinsonism, juvenile, autosomal recessive.
Lesage S; Lohmann E; Tison F; Durif F; Dürr A; Brice A
Hum Genet; 2008 Feb; 123(1):114. PubMed ID: 18386383
[No Abstract] [Full Text] [Related]
11. Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations.
Sammler EM; Swingler RJ; Stuart A; Muqit M
Mov Disord; 2009 Dec; 24(16):2442-3. PubMed ID: 19891003
[No Abstract] [Full Text] [Related]
12. Parkin gene variations and parkinsonism: association does not imply causation.
Langston JW; Tanner CM; Schüle B
Ann Neurol; 2007 Jan; 61(1):4-6. PubMed ID: 17262853
[No Abstract] [Full Text] [Related]
13. Expanding phenotype and clinical heterogeneity in patients with identical mutation of the parkin gene.
Kunishige M; Mitsui T; Kuroda Y; Yoshida S; Kosaka M; Matsumoto T
Eur Neurol; 2004; 51(3):183-5. PubMed ID: 15073448
[No Abstract] [Full Text] [Related]
14. Does failure of parkin-mediated ubiquitination cause juvenile parkinsonism?
Kahle PJ; Leimer U; Haass C
Trends Biochem Sci; 2000 Nov; 25(11):524-7. PubMed ID: 11084358
[No Abstract] [Full Text] [Related]
15. Marked diurnal fluctuation and rest benefit in a patient with parkin mutation.
Chung SJ; Park HK; Ki CS; Kim MJ; Lee MC
Mov Disord; 2008 Mar; 23(4):624-6. PubMed ID: 18228570
[No Abstract] [Full Text] [Related]
16. Parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism.
Poorkaj P; Moses L; Montimurro JS; Nutt JG; Schellenberg GD; Payami H
BMC Neurol; 2005 Feb; 5(1):4. PubMed ID: 15725358
[TBL] [Abstract][Full Text] [Related]
17. Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism.
Zimmermann M; Wilke C; Schulte C; Hoffmann J; Klopfer J; Reimold M; Brockmann K; Synofzik M
Parkinsonism Relat Disord; 2018 Oct; 55():145-147. PubMed ID: 29910155
[No Abstract] [Full Text] [Related]
18. Are parkin patients particularly suited for deep-brain stimulation?
Lohmann E; Welter ML; Fraix V; Krack P; Lesage S; Laine S; Tanguy ML; Houeto JL; Mesnage V; Pollak P; Durr A; Agid Y; Brice A;
Mov Disord; 2008 Apr; 23(5):740-3. PubMed ID: 18228569
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3eta is a novel regulator of parkin ubiquitin ligase.
Sato S; Chiba T; Sakata E; Kato K; Mizuno Y; Hattori N; Tanaka K
EMBO J; 2006 Jan; 25(1):211-21. PubMed ID: 16096643
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism.
Illarioshkin SN; Periquet M; Rawal N; Lücking CB; Zagorovskaya TB; Slominsky PA; Miloserdova OV; Markova ED; Limborska SA; Ivanova-Smolenskaya IA; Brice A
Mov Disord; 2003 Aug; 18(8):914-9. PubMed ID: 12889082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
